The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Novartis; Onclave Therapeutics; Sanofi; Xcenda
Research Funding - Acceleron Pharma; Agensys; Merck; Pfizer
 
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche/Genentech
CheckMate 025 phase III trial: Outcomes by key baseline factors and prior therapy for nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC).
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Padmanee Sharma
Stock and Other Ownership Interests - Jounce Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Jounce Therapeutics; MedImmune
 
David F. McDermott
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
Research Funding - Prometheus
 
Saby George
No Relationships to Disclose
 
Hans J. Hammers
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Newlink Genetics (Inst); Pfizer (Inst); SFJ Pharmaceuticals Group (Inst); TRACON Pharma (Inst)
 
Sandhya Srinivas
Consulting or Advisory Role - Genentech/Roche; medivation; pfizer
 
Scott S. Tykodi
Consulting or Advisory Role - Amgen; Prometheus (Inst)
Research Funding - Argos Therapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); immatics (Inst); Novartis (Inst)
 
Jeffrey Alan Sosman
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Novartis (Inst)
 
Giuseppe Procopio
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Ortho; Novartis; pfizer
 
Elizabeth R. Plimack
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Dendreon; Genentech; Merck; Novartis
Research Funding - Acceleron Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending (Inst)
 
Daniel E. Castellano
No Relationships to Disclose
 
Howard Gurney
Consulting or Advisory Role - Astellas Pharma; Bayer; Novartis; Pfizer; Sanofi
 
Frede Donskov
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
 
Petri Bono
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Orion; Pfizer
 
John Wagstaff
No Relationships to Disclose
 
Thomas Christoph Gauler
Stock and Other Ownership Interests - Bayer
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD; Novartis
 
Takeshi Ueda
No Relationships to Disclose
 
Huanyu Zhao
Employment - Bristol-Myers Squibb; GlaxoSmithKline
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline
 
Ian M Waxman
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Bernard Escudier
No Relationships to Disclose